语言版本

Time of issue:2021-09-02 16:56:33

中文 English





搜索

Search





Homepage

/

Product

/

API

All categories



No.	Name	CAS #	US-DMF	EDMF	CEP	CANADA MF	JAPAN DMF	KDMF	WHO	CHINA CDE	WC^*
1	Acitretin	55079-83-9	√	√	√	√				√	√
2	Acrivastine	87848-99-5	√	√						√	√
3	Adapalene	106685-40-9								√
4	Alitretinoin	5300-03-8		√				√			√
5	Anastrozole	120511-73-1								√
6	Bendamustine HCl	3543-75-7	√	√			√	√		√	√
7	Benidipine HCl	91599-74-5								√
8	Bepotastine Besilate	190786-44-8	√	√						√
9	Benzoyl Peroxide	2685-64-5								√
10	Bexarotene	153559-49-0	√	√							√
11	Betamethasone Sodium Phosphate	151-73-5								√
12	Bilastine	202189-78-4		√
13	Calcipotriol Anhydrous	112965-21-6	√	√			√			√	√
14	Calcipotriol Monohydrate	147657-22-5	√	√			√	√		√	√
15	Calcium Levofolinate	80433-71-2		√				√		√	√
16	Crizotinib	877399-52-5								√
17	Dapsone	80-08-0	√	√						√	√
18	Desonide	638-94-8								√
19	Isotretinoin	4759-48-2	√	√	√		√	√		√	√
20	Levocetirizine HCl	130018-87-0	√	√						√	√
21	Linezolid	165800-03-3	√	√						√	√
22	Moxifloxacin HCl	186826-86-8	√	√			√	√	√	√	√
23	Naftifine HCl	65473-14-5	√	√				√		√	√
24	Nintedanib esylate	656247-18-6								√
25	Olopatadine HCl	140462-76-6	√	√			√			√	√
26	Paricalcitol	131918-61-1	√	√						√	√
27	Palonosetron HCl	135729-62-3		√						√
28	Posaconazole	171228-49-2								√	√
29	Rivaroxaban	366789-02-8								√
30	Roflumilast	162401-32-3	√	√							√
31	Ruxolitinib phosphate	1092939-17-7	√	√		√				√	√
32	Ruxolitinib Mesylate	2927441-77-6		√		√
33	Tadalafil	171596-29-5
34	Tazarotene	118292-40-3		√						√	√
35	Tretinoin	302-79-4	√	√	√			√		√	√

Finerenone

Number of views:

1000

Keywords:

Fulvestrant

FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Number of views:

1000

Keywords:

treatment

disease

indicated

metastatic

in

for

progression

is

faslodex

Nintedanib esylate

Nintedanib esylate is a small molecule tyrosine kinase inhibitor with antifibrotic and anti-inflammatory activities for the treatment of idiopathic pulmonary fibrosis.

Number of views:

1000

Keywords:

small

treatment

for

pulmonary

is

the

with

fibrosis.

kinase

Ruxolitinib phosphate

Ruxolitinib phosphate is indicated for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis (PMF) (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis (PPV-MF), orpost-essential thrombocythemia myelofibrosis (PET-MF).

Number of views:

1000

Keywords:

myelofibrosis

known

Bendamustine HCl

Bendamustine HCl was originally manufactured in East Germany (former German Democratic Republic) in 1963.

Number of views:

1000

Keywords:

Bendamustine

treatment

Olopatadine HCl

Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996,

Number of views:

1000

Keywords:

Olopatadine

Patanol